# EDGAR Filing Document

**Accession Number:** 0002042609
**File Stem:** 0001872856-26-000133
**Filing Date:** 2026-4
**Character Count:** 2724
**Document Hash:** 1f2d41132b4e3597800525569778907b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001872856-26-000133.hdr.sgml**: 20260429

**ACCESSION NUMBER**: 0001872856-26-000133

**CONFORMED SUBMISSION TYPE**: C-AR

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20251231

**FILED AS OF DATE**: 20260429

**DATE AS OF CHANGE**: 20260428

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Eliaz Therapeutics Inc.
- **CENTRAL INDEX KEY:** 0002042609

**ORGANIZATION NAME:**
- **EIN:** 475133162
- **STATE OF INCORPORATION:** DE

**FILING VALUES:**
- **FORM TYPE:** C-AR
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 020-35050
- **FILM NUMBER:** 26909549

**BUSINESS ADDRESS:**
- **STREET 1:** 398 TESCONI COURT
- **CITY:** SANTA ROSA
- **STATE:** CA
- **ZIP:** 95401
- **BUSINESS PHONE:** 6282664770

**MAIL ADDRESS:**
- **STREET 1:** 398 TESCONI COURT
- **CITY:** SANTA ROSA
- **STATE:** CA
- **ZIP:** 95401

### Attached PDF Documents

**Attachment 1:** `eliazformcar.pdf`

_No text found in this document._

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM C

### UNDER THE SECURITIES ACT OF 1933

### Issuer Information

**Name of Issuer:** Eliaz Therapeutics Inc.

**Legal Status:** Corporation

**Jurisdiction of Incorporation/Organization:** DE

**Date of Organization:** 09-17-2015

**Physical Address:** 398 TESCONI COURT, SANTA ROSA, CA, 95401

**Issuer Website:** https://www.eliaztherapeutics.com

**Is there a Co-Issuer?:** No

### Annual Report Disclosure Requirements

**Current Number of Employees:** 2.00

**Total Assets (Most Recent Fiscal Year):** $2,589,276.00

**Total Assets (Prior Fiscal Year):** $738,015.00

**Cash & Cash Equivalents (Most Recent Fiscal Year):** $1,799,510.00

**Cash & Cash Equivalents (Prior Fiscal Year):** $32,814.00

**Accounts Receivable (Most Recent Fiscal Year):** $0.00

**Accounts Receivable (Prior Fiscal Year):** $0.00

**Short-Term Debt (Most Recent Fiscal Year):** $1,796,731.00

**Short-Term Debt (Prior Fiscal Year):** $2,346,085.00

**Long-Term Debt (Most Recent Fiscal Year):** $8,033,117.00

**Long-Term Debt (Prior Fiscal Year):** $3,888,186.00

**Revenues/Sales (Most Recent Fiscal Year):** $332,235.00

**Revenues/Sales (Prior Fiscal Year):** $302,481.00

**Cost of Goods Sold (Most Recent Fiscal Year):** $0.00

**Cost of Goods Sold (Prior Fiscal Year):** $0.00

**Taxes Paid (Most Recent Fiscal Year):** $0.00

**Taxes Paid (Prior Fiscal Year):** $0.00

**Net Income (Most Recent Fiscal Year):** $-1,745,041.00

**Net Income (Prior Fiscal Year):** $-954,869.00

### Signatures

**Issuer:** Eliaz Therapeutics Inc.

**Signature:** Isaac Eliaz

**Title:** Chief Executive Officer

---

**Signature:** Isaac Eliaz

**Title:** Director

**Date:** 04-28-2026